Q2 2024 KORU Medical Systems Inc Earnings Call Transcript
Key Points
- KORU Medical Systems Inc (KRMD) reported record revenues of $8.4 million for Q2 2024, marking a 22% growth over the same period in 2023.
- The company achieved a 46% year-over-year growth in its international core business, driven by improved IG supply and increased penetration in CIDP and SID approved indications.
- KORU Medical Systems Inc (KRMD) received regulatory clearance for its FREEDOM EDGE infusion system in Japan, expanding its international reach.
- The company improved its gross margin to 65%, an 890 basis point increase compared to the prior year, due to manufacturing efficiencies.
- KORU Medical Systems Inc (KRMD) raised its 2024 full-year revenue and gross margin guidance, reflecting confidence in continued growth and operational improvements.
- The company anticipates more pressure on margins due to expanding into lower SP lesions and ongoing inflationary pressures in the supply chain.
- KORU Medical Systems Inc (KRMD) expects higher cash usage in the second half of the year, driven by capital investments and R&D project spending.
- The company noted a $300,000 accelerated shipment in Q2 that is not expected to recur, potentially impacting future revenue growth.
- There is uncertainty regarding the impact of the expanded label for SCIG therapy, as it depends on healthcare practitioner adoption.
- KORU Medical Systems Inc (KRMD) faces challenges in timing novel therapies revenues, which can be delayed due to collaboration complexities.
Greetings and welcome to the KORU Medical Systems Second Quarter 2024 earnings call. At this time, all participants are in a listen only mode, a brief question and answer session will follow the formal presentation. Anyone should require operator assistance during the conference, please press star and then zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Louisa Smith. Thank you. You may begin.
Good afternoon, everyone. Joining me on the call today are Linda Tharby, President and CEO of KORU Medical Systems, and Tom Adams, Chief Financial Officer. Earlier today, core medical systems released financial results for the second quarter ended June 30th, 2024. The copy of the press release is available on the company's website. I encourage listeners to have our press release in front of you, which includes our financial results as well as commentary on the quarter. Additionally, we will use slides to support commentary in today's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
